MedTrace Logo

A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults

NCT00583154 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-09-28

No results posted yet for this study

Summary

To compare the safety and efficacy of BLI-801 administered at 4 dose levels in constipated adults.

Conditions

Interventions

DRUG

BLI-801

Dose 1

DRUG

BLI-801

Dose 2

DRUG

BLI-801

Dose 3

DRUG

BLI-801

Dose 4

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • John McGowan · Braintree Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583154 on ClinicalTrials.gov